Bnp Paribas Arbitrage, Snc »

Gt Biopharma shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-03-31 $27 6 4.50

More positions owned by Bnp Paribas Arbitrage, Snc

Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
NVIDIA Corp Equity (NVDA)
Meta Platforms Equity (META)
Amazon.com Equity (AMZN)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Advanced Micro Devices Equity (AMD)
Industrial Select Sector SPDR Fund Fund (XLI)
Exxon Mobil Corp Equity (XOM)
iShares Russell 2000 ETF Fund (IWM)
Visa Equity (V)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOG)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Gt Biopharma

DekaBank Deutsche Girozentrale
Vanguard Group
Bank Of Montreal
Geode Capital Management
BlackRock
Wells Fargo & Company
Tower Research Capital
UBS Group
Morgan Stanley
FMR
Advisor Group Holdings
Bank of America Corporation
Blue Bell Private Wealth Management
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc

View all funds holding Gt Biopharma